药物警戒的当前趋势：患者报告的价值与差距 - Suppr

Current trends in pharmacovigilance: value and gaps of patient reporting.

作者信息

Inácio Pedro, Cavaco Afonso, Airaksinen Marja

机构信息

Clinical Pharmacy Group, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, P. O. Box 56, 00014, Helsinki, Finland.

iMed.ULisboa Research Institute for Medicines and Pharmaceutical Sciences, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.

出版信息

Int J Clin Pharm. 2018 Aug;40(4):754-757. doi: 10.1007/s11096-018-0689-6. Epub 2018 Jul 13.

DOI:10.1007/s11096-018-0689-6

PMID:30006734

Abstract

摘要

相似文献

Current trends in pharmacovigilance: value and gaps of patient reporting.药物警戒的当前趋势：患者报告的价值与差距

Int J Clin Pharm. 2018 Aug;40(4):754-757. doi: 10.1007/s11096-018-0689-6. Epub 2018 Jul 13.

Fifteen years of patient reporting -what have we learned and where are we heading to?十五年的患者报告——我们学到了什么，未来的方向在哪里？

Expert Opin Drug Saf. 2019 Jun;18(6):477-484. doi: 10.1080/14740338.2019.1613373. Epub 2019 May 16.

Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.迈向药物安全监测与药物警戒：从电子健康记录中检测用药及药物不良事件的当前进展

Drug Saf. 2019 Jan;42(1):95-97. doi: 10.1007/s40264-018-0766-8.

The value of patient reporting to the pharmacovigilance system: a systematic review.患者向药物警戒系统报告的价值：一项系统评价

Br J Clin Pharmacol. 2017 Feb;83(2):227-246. doi: 10.1111/bcp.13098. Epub 2016 Oct 12.

Fifty years of pharmacovigilance - Medicines safety and public health.五十年药物警戒——药品安全与公众健康

Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):725-32. doi: 10.1002/pds.3967. Epub 2016 Jan 22.

Report of Adverse Events in Colombia: A Successful Case.哥伦比亚不良事件报告：一个成功案例。

Curr Drug Saf. 2019;14(1):53-56. doi: 10.2174/1574886313666181109150648.

[Direct reporting by patients of adverse drug reactions in Spain].[西班牙患者对药物不良反应的直接报告]

Farm Hosp. 2013 Jan-Feb;37(1):65-71. doi: 10.7399/FH.2013.37.1.121.

Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.药品不良反应报告不足：印度药物警戒面临的一项挑战。

Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71. doi: 10.4103/0253-7613.150344.

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况：文献回顾、描述性和定性分析以及问卷调查。

Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.

Ongoing challenges in pharmacovigilance.药物警戒中的持续挑战。

Drug Saf. 2014 Jan;37(1):1-8. doi: 10.1007/s40264-013-0123-x.

引用本文的文献

Assessment of public awareness and perspectives towards adverse drug reaction reporting system in Karachi, Pakistan.巴基斯坦卡拉奇市公众对药品不良反应报告系统的认知及看法评估

PLoS One. 2025 Feb 10;20(2):e0318139. doi: 10.1371/journal.pone.0318139. eCollection 2025.

Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study.消费者对使用数字工具报告药物不良反应的看法：一项横断面研究。

Int J Clin Pharm. 2025 Apr;47(2):423-434. doi: 10.1007/s11096-024-01847-2. Epub 2024 Dec 19.

Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting.约旦人在药品不良反应报告方面的知识、态度和做法。

Saudi Pharm J. 2023 Jul;31(7):1197-1201. doi: 10.1016/j.jsps.2023.05.016. Epub 2023 May 18.

A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.一项横断面研究：比较中东部和中西部地区公众对药品不良反应报告和监测的认知。

BMC Health Serv Res. 2022 Mar 8;22(1):318. doi: 10.1186/s12913-022-07720-0.

Teaching Pharmacovigilance to Healthcare Students: Identifying Gaps and Opportunities for Improvement.向医学生传授药物警戒知识：识别改进的差距与机遇

Pharmacy (Basel). 2021 Aug 26;9(3):147. doi: 10.3390/pharmacy9030147.

Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era.指导药物警戒中心在 COVID-19 时代进行药物安全管理的轴心。

Int J Clin Pharm. 2021 Aug;43(4):1133-1138. doi: 10.1007/s11096-021-01289-0. Epub 2021 Jun 2.

Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.尼日利亚门诊患者对不良反应的知识、意识、看法和报告。

Int J Clin Pharm. 2019 Aug;41(4):1062-1073. doi: 10.1007/s11096-019-00849-9. Epub 2019 May 28.

Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project".关于《社交媒体在药物警戒中广泛统计信号检测的效用评估：WEB-RADR项目的结果》的评论

Drug Saf. 2018 Dec;41(12):1371-1373. doi: 10.1007/s40264-018-0747-y.

Overview of this issue: pharmacovigilance, what is new?本期概述：药物警戒，有哪些新进展？

Int J Clin Pharm. 2018 Aug;40(4):737-739. doi: 10.1007/s11096-018-0719-4.

本文引用的文献

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.用于复发缓解型多发性硬化症患者报告药物不良反应的专用移动应用程序（Vigip-SEP研究）：一项随机对照试验的研究方案

Trials. 2018 Mar 9;19(1):174. doi: 10.1186/s13063-018-2560-4.

Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union.关键药物警戒利益相关者对欧盟患者直接报告药物不良反应的体验及其未来发展前景。

Public Health. 2018 Feb;155:119-128. doi: 10.1016/j.puhe.2017.11.023. Epub 2018 Jan 12.

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.使用 VigiBase 在协作信号检测研讨会上报告的患者报告的安全问题：Lareb 和 Uppsala 监测中心的结果和反思。

Drug Saf. 2018 Feb;41(2):203-212. doi: 10.1007/s40264-017-0594-2.

The key role of clinical and community health nurses in pharmacovigilance.临床和社区健康护士在药物警戒中的关键作用。

Eur J Clin Pharmacol. 2017 Nov;73(11):1379-1387. doi: 10.1007/s00228-017-2309-0. Epub 2017 Aug 2.

The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.2010年至2015年期间，荷兰患者直接报告的药品不良反应对药物安全信号的贡献。

Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):977-983. doi: 10.1002/pds.4236. Epub 2017 May 19.

Patient Reporting in the EU: Analysis of EudraVigilance Data.欧盟的患者报告：EudraVigilance数据的分析。

Drug Saf. 2017 Jul;40(7):629-645. doi: 10.1007/s40264-017-0534-1.

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.患者和医疗保健专业人员提交的药品不良反应报告中的临床信息质量：一项回顾性比较分析

Drug Saf. 2017 Jul;40(7):607-614. doi: 10.1007/s40264-017-0530-5.

Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?患者药物不良反应初始报告的信息量。药物警戒中心能否对其进行改善？

Eur J Clin Pharmacol. 2017 Aug;73(8):1009-1018. doi: 10.1007/s00228-017-2254-y. Epub 2017 Apr 8.

Factors affecting patient reporting of adverse drug reactions: a systematic review.影响患者药物不良反应报告的因素：一项系统评价

Br J Clin Pharmacol. 2017 Apr;83(4):875-883. doi: 10.1111/bcp.13159. Epub 2016 Nov 25.

Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.全科医生向地区药物警戒中心发送的自发药品不良反应报告的完整性：一项描述性研究。

Drug Saf. 2016 Dec;39(12):1189-1195. doi: 10.1007/s40264-016-0463-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Current trends in pharmacovigilance: value and gaps of patient reporting.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献